Discovery of 3-piperidinyl-1-cyclopentanecarboxamide as a novel scaffold for highly potent CC chemokine receptor 2 antagonists
L Yang, G Butora, RX Jiao, A Pasternak…
Index: Yang, Lihu; Butora, Gabor; Jiao, Richard X.; Pasternak, Alex; Zhou, Changyou; Parsons, William H.; Mills, Sander G.; Vicario, Pasquale P.; Ayala, Julia M.; Cascieri, Margaret A.; MacCoss, Malcolm Journal of Medicinal Chemistry, 2007 , vol. 50, # 11 p. 2609 - 2611
Full Text: HTML
Citation Number: 30
Abstract
Introduction of ring restrictions to a linear aminobutyramide CC chemokine receptor 2 (CCR2) antagonist lead (2) led to the discovery of a 1, 3-disubstituted cyclopentane scaffold with enhanced hCCR2 receptor binding and antagonist activity.(1 S, 3 R)-N-[3, 5-Bis (trifluoromethyl) benzyl]-1-methyl-3-[(1 R, 3'R)-methyl-1'H-spiro [indene-1, 4'-piperidin]-1'-yl] cyclopentanecarboxamide (16) had IC50 of 1.3 nM (binding) and 0.45 nM (functional ...
Related Articles:
[Khoukhi, N.; Vaultier, M.; Carrie, R. Tetrahedron, 1987 , vol. 43, # 8 p. 1811 - 1822]
[Daoust, Benoit; Lessard, Jean Tetrahedron, 1999 , vol. 55, # 12 p. 3495 - 3514]